Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Singer

Showing results (431-440 of 649) with videos related to

Pageof 65
Sort By:
Endocrine-Related Cancer|October 25, 2008
Incomplete surgical resection of ductal carcinomas in situ results in activation of ERBB2 in residual breast cancer cellsChristian F Singer, Gernot Hudelist, Eva-Maria Fuchs, et al.
Cancers|May 4, 2026
Gene-Specific Outcomes After Central Nervous System Metastases in Germline BRCA1- and BRCA2-Associated Breast CancerAlice Decaminada, Raute Sunder-Plassmann, Weang-Kee Ho, et al.
The European Journal of Neuroscience|November 28, 2015
Individual variation in incentive salience attribution and accumbens dopamine transporter expression and functionBryan F Singer, Bipasha Guptaroy, Curtis J Austin, et al.
BMC Cancer|March 28, 2023
Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer"Christine Deutschmann, Christian F Singer, Daphne Gschwantler-Kaulich, et al.
Human Reproduction (Oxford, England)|August 29, 2014
A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrheaB Böttcher, R M Laterza, L Wildt, et al.
ESMO Open|March 25, 2022
Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18C Minichsdorfer, T Fuereder, M Leutner, et al.
Current Cancer Drug Targets|November 25, 2011
Presence of intratumoral stem cells in breast cancer patients with or without BRCA germline mutationsC F Singer, P Zabkova, C Rappaport, et al.
Anticancer Research|May 25, 2004
Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancerWolfgang J Köstler, Günther G Steger, Afschin Soleiman, et al.
International Journal of Cancer|September 15, 2005
Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancerGernot Hudelist, Wolfgang J Köstler, Klaus Czerwenka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast CancerChristian F Singer, , Frederik Holst, et al.
Pageof 65

Showing results (431-440 of 649) with videos related to

Sort By:
Pageof 65
Endocrine-Related Cancer|October 25, 2008
Incomplete surgical resection of ductal carcinomas in situ results in activation of ERBB2 in residual breast cancer cellsChristian F Singer, Gernot Hudelist, Eva-Maria Fuchs, et al.
Cancers|May 4, 2026
Gene-Specific Outcomes After Central Nervous System Metastases in Germline BRCA1- and BRCA2-Associated Breast CancerAlice Decaminada, Raute Sunder-Plassmann, Weang-Kee Ho, et al.
The European Journal of Neuroscience|November 28, 2015
Individual variation in incentive salience attribution and accumbens dopamine transporter expression and functionBryan F Singer, Bipasha Guptaroy, Curtis J Austin, et al.
BMC Cancer|March 28, 2023
Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer"Christine Deutschmann, Christian F Singer, Daphne Gschwantler-Kaulich, et al.
Human Reproduction (Oxford, England)|August 29, 2014
A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrheaB Böttcher, R M Laterza, L Wildt, et al.
ESMO Open|March 25, 2022
Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18C Minichsdorfer, T Fuereder, M Leutner, et al.
Current Cancer Drug Targets|November 25, 2011
Presence of intratumoral stem cells in breast cancer patients with or without BRCA germline mutationsC F Singer, P Zabkova, C Rappaport, et al.
Anticancer Research|May 25, 2004
Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancerWolfgang J Köstler, Günther G Steger, Afschin Soleiman, et al.
International Journal of Cancer|September 15, 2005
Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancerGernot Hudelist, Wolfgang J Köstler, Klaus Czerwenka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast CancerChristian F Singer, , Frederik Holst, et al.
Pageof 65